Trill Impact Ventures and Bpifrance co-lead $25 million financing of May Health
Client(s) Trill Impact Ventures and Bpifrance
Jones Day advised Trill Impact Ventures and Bpifrance as lead investors in the $25 million Series B financing of May Health, a French-American medical device company targeting Polycystic Ovary Syndrome (PCOS) related infertility.